Consolidated Statements of Operations (USD $) In Millions, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Net sales	$ 7,143	$ 7,249	$ 7,622
Cost of products sold	2,174	2,349	2,659
Gross profit	4,969	4,900	4,963
Operating expenses:
Selling, general and administrative expenses	2,674	2,535	2,487
Research and development expenses	861	886	895
Royalty expense	140	153	172
Amortization expense	410	395	421
Goodwill impairment charges	423	4,350	697
Intangible asset impairment charges	53	142	21
Contingent consideration expense (benefit)	4	(6)	7
Restructuring charges	101	136	89
Litigation-related charges	221	192	48
Gain on divestiture	(38)	(15)	(778)
Operating expenses	4,849	8,768	4,059
Operating income (loss)	120	(3,868)	904
Other (expense) income:
Interest expense	(324)	(261)	(281)
Other, net	(19)	22	19
(Loss) income before income taxes	(223)	(4,107)	642
Income tax (benefit) expense	(102)	(39)	201
Net (loss) income	$ (121)	$ (4,068)	$ 441
Net (loss) income per common share — basic	$ (0.09)	$ (2.89)	$ 0.29
Net (loss) income per common share — assuming dilution	$ (0.09)	$ (2.89)	$ 0.29
Weighted-average shares outstanding
Basic	1,341.2	1,406.7	1,509.3
Assuming dilution	1,341.2	1,406.7	1,519.0